IL-10 suppressor activity andex vivo Tr1 cell function are impaired in multiple sclerosis (Q59854924)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

0 references

1 reference

0 references

Sara Martinez-Pasamar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jorge Sepulcre

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Pablo Villoslada

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ignacio Melero, MD-PhD

11

object named as

Ignacio Melero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Ivan Martinez-Forero

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ricardo Garcia-Munoz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Susana Inoges

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ascensión Lopez-Diaz de Cerio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ricardo Palacios

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Beatriz Moreno

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Zaira Gonzalez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Begoña Fernandez-Diez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Maurizio Bendandi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

576-586

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

A new primate model for multiple sclerosis in the common marmoset

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Regulatory T cells, tumour immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Regulatory T-cell therapy: is it ready for the clinic?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Tr1 cells: from discovery to their clinical application.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Cutting edge: abortive proliferation of CD46-induced Tr1-like cells due to a defective Akt/Survivin signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

OX40 ligand shuts down IL-10-producing regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Multiple sclerosis: a two-stage disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Immunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Lymphocyte function and the role of regulator cells in multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T cells during autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

CD46: expanding beyond complement regulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Interleukin-10 and related cytokines and receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Interferon beta induces T-helper 2 immune deviation in MS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Suppressor T cells in human diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Methylthioadenosine reverses brain autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737271

7 January 2021

Identifiers

DOI

10.1002/EJI.200737271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18200504%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference